These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 16981166)

  • 41. Dual desorption electrospray ionization-laser desorption ionization mass spectrometry on a common nanoporous alumina platform for enhanced shotgun proteomic analysis.
    Nayak R; Liu J; Sen AK; Knapp DR
    Anal Chem; 2008 Nov; 80(22):8840-4. PubMed ID: 18937429
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Identification of protein biomarkers for schizophrenia and bipolar disorder in the postmortem prefrontal cortex using SELDI-TOF-MS ProteinChip profiling combined with MALDI-TOF-PSD-MS analysis.
    Novikova SI; He F; Cutrufello NJ; Lidow MS
    Neurobiol Dis; 2006 Jul; 23(1):61-76. PubMed ID: 16549361
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Improving sample treatment for in-solution protein identification by peptide mass fingerprint using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
    Santos HM; Rial-Otero R; Fernandes L; Vale G; Rivas MG; Moura I; Capelo JL
    J Proteome Res; 2007 Sep; 6(9):3393-9. PubMed ID: 17683131
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Identification of protein biomarkers in Dupuytren's contracture using surface enhanced laser desorption ionization time-of-flight mass spectrometry (SELDI-TOF-MS).
    O'Gorman D; Howard JC; Varallo VM; Cadieux P; Bowley E; McLean K; Pak BJ; Gan BS
    Clin Invest Med; 2006 Jun; 29(3):136-45. PubMed ID: 17058431
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A peptidomic approach for monitoring and characterising peptide cyanotoxins produced in Italian lakes by matrix-assisted laser desorption/ionisation and quadrupole time-of-flight mass spectrometry.
    Ferranti P; Nasi A; Bruno M; Basile A; Serpe L; Gallo P
    Rapid Commun Mass Spectrom; 2011 May; 25(9):1173-83. PubMed ID: 21488115
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cardiovascular biomarker discovery by SELDI-TOF mass spectrometry.
    Meilhac O; Delbosc S; Michel JB
    Methods Mol Biol; 2007; 357():331-41. PubMed ID: 17172699
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Oncoproteomics: state-of-the-art.
    Jain KK
    Technol Cancer Res Treat; 2002 Aug; 1(4):219-20. PubMed ID: 12625779
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pharmacogenomics and clinical biomarkers in drug discovery and development.
    Ross JS; Symmans WF; Pusztai L; Hortobagyi GN
    Am J Clin Pathol; 2005 Dec; 124 Suppl():S29-41. PubMed ID: 16468416
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Neuro-oncology: new insights and advances in treatment.
    Soffietti R; Rudà R
    Lancet Neurol; 2008 Jan; 7(1):14-6. PubMed ID: 18093552
    [No Abstract]   [Full Text] [Related]  

  • 50. Neuro-oncology: a call for papers.
    Frankish H; Collingridge D
    Lancet Neurol; 2009 Jan; 8(1):31. PubMed ID: 19081512
    [No Abstract]   [Full Text] [Related]  

  • 51. Highlights of the annual meeting of the Italian Association for Cell Cultures (AICC): new drug delivery strategies and technological platforms for diagnosis and therapy of tumors (Part I) 6 - 7 December 2007, Naples, Italy.
    Caraglia M; Marra M; Budillon A
    Expert Opin Biol Ther; 2008 Jun; 8(6):845-54. PubMed ID: 18476796
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Neuro-oncology: continuing multidisciplinary progress.
    Nagane M
    Lancet Neurol; 2011 Jan; 10(1):18-20. PubMed ID: 21163442
    [No Abstract]   [Full Text] [Related]  

  • 53. Neuro-oncology: setting new standards of management.
    Graus F; Tortosa A
    Lancet Neurol; 2006 Jan; 5(1):8-9. PubMed ID: 16361010
    [No Abstract]   [Full Text] [Related]  

  • 54. Single pediatric neuro-oncology center may make difference in low/middle-income countries.
    Zaghloul MS
    Childs Nerv Syst; 2016 Feb; 32(2):241-2. PubMed ID: 26715299
    [No Abstract]   [Full Text] [Related]  

  • 55. New Neuro-Oncology Practice journal to launch in 2014.
    Chang S; Yung WK
    Neuro Oncol; 2013 Oct; 15(10):1277. PubMed ID: 24057884
    [No Abstract]   [Full Text] [Related]  

  • 56. Abstracts of the Annual Meeting of the British Neuro-oncology Society (BNOS). Preston, United Kingdom. June 25-27, 2008.
    Br J Neurosurg; 2008 Jun; 22(3):310-38. PubMed ID: 18568720
    [No Abstract]   [Full Text] [Related]  

  • 57. Neuro-oncology in 2016: Advances in brain tumour classification and therapy.
    Preusser M; Marosi C
    Nat Rev Neurol; 2017 Feb; 13(2):71-72. PubMed ID: 28106065
    [No Abstract]   [Full Text] [Related]  

  • 58. Introduction. Neurooncology: update on therapeutic options.
    Fults DW; Chen T; Bruce JN
    Neurosurg Focus; 2015 Mar; 38(3):E1. PubMed ID: 25727218
    [No Abstract]   [Full Text] [Related]  

  • 59. Therapeutic Advances in Neuro-Oncology.
    McFaline-Figueroa JR; Lee EQ; Wen PY
    Neurotherapeutics; 2022 Oct; 19(6):1689-1690. PubMed ID: 36344725
    [No Abstract]   [Full Text] [Related]  

  • 60. Special Supplement: Global Neuro-Oncology.
    Enam SA; Aziz HF; Siddiqui K; Bajwa MH; Urooj F; Bakhshi SK; Khan AA; Park KB; Khan T
    J Pak Med Assoc; 2024 Mar; 74(3 (Supple-3)):S1. PubMed ID: 39262059
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.